Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice
{{output}}
Messenger RNA (mRNA) vaccines and computationally designed protein nanoparticle vaccines were both clinically derisked and licensed for the first time during the coronavirus disease 2019 (COVID-19) pandemic. These vaccine modalities have complementary immunolo... ...
